Sort   by:  
 Page size 
UnknownEndogenous EWSR1-FLI1 degron alleles enable control of fusion oncoprotein expression in tumor cell lines and xenografts.
Not available
S-EPMC11566046 | biostudies-literature
UnknownCo-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.
Not available
S-EPMC8355076 | biostudies-literature
UnknownCharacteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Not available
S-EPMC6171146 | biostudies-literature
UnknownSCINA: A Semi-Supervised Subtyping Algorithm of Single Cells and Bulk Samples.
Not available
S-EPMC6678337 | biostudies-literature
Unknownp63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas.
Not available
S-EPMC7048935 | biostudies-literature
UnknownSARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques.
Not available
S-EPMC7359530 | biostudies-literature
UnknownDevelopment of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity.
Not available
S-EPMC11978227 | biostudies-literature
UnknownEngineered reduction of S-adenosylmethionine alters lignin in sorghum.
Not available
S-EPMC11481400 | biostudies-literature
UnknownBurosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Not available
S-EPMC11059996 | biostudies-literature
UnknownBurosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Not available
S-EPMC7179969 | biostudies-literature
Sort   by:  
 Page size